Condition: Functional Abdominal Pain Syndrome · Functional Gastrointestinal Disorders · Irritable Bowel Syndrome Variant of Childhood · Sponsor: Universidad de Colima
The goal of this clinical trial is to test the effectiveness of trimebutine and probiotics in treating Functional Abdominal Pain Disorders (FAPD) in a pediatric population. The main questions it aims to answer are: Is trimebutine effective in reducing the symptoms of FAPD in children? Are probiotics effective in reducing the symptoms of FAPD in children? Participants will be randomly assigned to one of three treatment groups (trimebutine/probiotics, probiotics/placebo, or trimebutine/placebo). Undergo measurements for pain and other relevant metrics at the start of the study, after 4 weeks, and after 8 weeks. Researchers will compare the trimebutine/probiotics group to the probiotics/placebo and the trimebutine/placebo groups to see if there are significant differences in the efficacy of these treatments in reducing symptoms of FAPD in children.
This description comes directly from the study's public registry record.
Pablo H Sandoval-Villaseñor, MD · +523123007655 · pablohernan_sandoval@ucol.mx
Fabián Rojas-Larios, PhD · +523121206804 · frojas@ucol.mx
Always discuss trial participation with your own doctor first.
| School of Medicine, University of Colima | Colima, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06268964